UY27632A1 - Metabolitos del ácido (3-((4- terc- butilbencil)-piridin.3- sulfonil) amino) metil ) fenoxi) acético - Google Patents
Metabolitos del ácido (3-((4- terc- butilbencil)-piridin.3- sulfonil) amino) metil ) fenoxi) acéticoInfo
- Publication number
- UY27632A1 UY27632A1 UY27632A UY27632A UY27632A1 UY 27632 A1 UY27632 A1 UY 27632A1 UY 27632 A UY27632 A UY 27632A UY 27632 A UY27632 A UY 27632A UY 27632 A1 UY27632 A1 UY 27632A1
- Authority
- UY
- Uruguay
- Prior art keywords
- metabolites
- phenoxy
- amino
- methyl
- acetic
- Prior art date
Links
- -1 AMINO Chemical class 0.000 title abstract 2
- 239000002207 metabolite Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente invención se refiere a metabolitos del ácido (3-( ( 4- tercbutilbencil)-(piridin-3-sulfonil)amino)metil)fenoxi)acético.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35374802P | 2002-01-31 | 2002-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27632A1 true UY27632A1 (es) | 2003-08-29 |
Family
ID=27663249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27632A UY27632A1 (es) | 2002-01-31 | 2003-01-30 | Metabolitos del ácido (3-((4- terc- butilbencil)-piridin.3- sulfonil) amino) metil ) fenoxi) acético |
Country Status (29)
Country | Link |
---|---|
US (1) | US6852863B2 (es) |
EP (1) | EP1470109A1 (es) |
JP (1) | JP2005521668A (es) |
KR (1) | KR20040077884A (es) |
CN (1) | CN1625549A (es) |
AP (1) | AP2004003094A0 (es) |
AR (1) | AR038332A1 (es) |
BR (1) | BR0307339A (es) |
CA (1) | CA2473984A1 (es) |
EA (1) | EA200400724A1 (es) |
EC (1) | ECSP045215A (es) |
GB (1) | GB2400100B (es) |
HN (1) | HN2003000051A (es) |
HR (1) | HRP20040683A2 (es) |
HU (1) | HUP0500012A2 (es) |
IL (1) | IL162167A0 (es) |
IS (1) | IS7281A (es) |
MA (1) | MA27169A1 (es) |
MX (1) | MXPA04004960A (es) |
NO (1) | NO20043569D0 (es) |
OA (1) | OA12760A (es) |
PA (1) | PA8564601A1 (es) |
PE (1) | PE20030978A1 (es) |
PL (1) | PL371982A1 (es) |
TN (1) | TNSN04138A1 (es) |
TW (1) | TW200302080A (es) |
UY (1) | UY27632A1 (es) |
WO (1) | WO2003064391A1 (es) |
ZA (1) | ZA200404067B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
TWI332937B (en) * | 2005-04-20 | 2010-11-11 | Lg Chemical Ltd | Additive for non-aqueous electrolyte and secondary battery using the same |
EP2059507B1 (en) * | 2006-07-28 | 2013-03-20 | Pfizer Products Inc. | Ep2 agonist |
JP2010523476A (ja) | 2007-03-08 | 2010-07-15 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | ミトコンドリアアルデヒドデヒドロゲナーゼ−2モジュレーター及びその使用方法 |
EP2002834A1 (de) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryl/Hetarylamide als Modulatoren des EP2-Rezeptors |
CA2718393C (en) * | 2008-03-12 | 2015-06-16 | Ube Industries, Ltd. | Pyridylaminoacetic acid compound |
EP2149551A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | N-(Indol-3-ylalkyl)-(hetero)arylamidderivate als Modulatoren des EP2-Rezeptors |
EP2149552A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors |
EP2149554A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma Aktiengesellschaft | Indolylamide als Modulatoren des EP2-Rezeptors |
JP2012502048A (ja) * | 2008-09-08 | 2012-01-26 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法 |
JP2012506856A (ja) | 2008-10-28 | 2012-03-22 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法 |
HUE026742T2 (en) | 2009-03-30 | 2016-07-28 | Ube Industries | A pharmaceutical composition for the treatment or prevention of glaucoma |
DE102009049662A1 (de) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten |
US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
TW201326154A (zh) | 2011-11-28 | 2013-07-01 | 拜耳知識產權公司 | 作為ep2受體拮抗劑之新穎2h-吲唑 |
CN105358531B (zh) | 2013-03-14 | 2017-11-14 | 利兰-斯坦福大学初级学院的董事会 | 线粒体醛脱氢酶‑2调节剂和其使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA67754C2 (uk) | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
-
2003
- 2003-01-20 GB GB0413967A patent/GB2400100B/en not_active Expired - Fee Related
- 2003-01-20 MX MXPA04004960A patent/MXPA04004960A/es unknown
- 2003-01-20 EA EA200400724A patent/EA200400724A1/ru unknown
- 2003-01-20 WO PCT/IB2003/000121 patent/WO2003064391A1/en active Application Filing
- 2003-01-20 BR BR0307339-4A patent/BR0307339A/pt not_active IP Right Cessation
- 2003-01-20 KR KR10-2004-7011618A patent/KR20040077884A/ko not_active Application Discontinuation
- 2003-01-20 JP JP2003564014A patent/JP2005521668A/ja active Pending
- 2003-01-20 OA OA1200400198A patent/OA12760A/en unknown
- 2003-01-20 CA CA002473984A patent/CA2473984A1/en not_active Abandoned
- 2003-01-20 CN CNA038029952A patent/CN1625549A/zh active Pending
- 2003-01-20 AP APAP/P/2004/003094A patent/AP2004003094A0/en unknown
- 2003-01-20 EP EP03700072A patent/EP1470109A1/en not_active Withdrawn
- 2003-01-20 IL IL16216703A patent/IL162167A0/xx unknown
- 2003-01-20 HU HU0500012A patent/HUP0500012A2/hu unknown
- 2003-01-20 PL PL03371982A patent/PL371982A1/xx not_active Application Discontinuation
- 2003-01-24 TW TW092101619A patent/TW200302080A/zh unknown
- 2003-01-28 PE PE2003000086A patent/PE20030978A1/es not_active Application Discontinuation
- 2003-01-28 HN HN2003000051A patent/HN2003000051A/es unknown
- 2003-01-29 US US10/353,671 patent/US6852863B2/en not_active Expired - Fee Related
- 2003-01-29 AR ARP030100254A patent/AR038332A1/es unknown
- 2003-01-30 PA PA20038564601A patent/PA8564601A1/es unknown
- 2003-01-30 UY UY27632A patent/UY27632A1/es not_active Application Discontinuation
-
2004
- 2004-05-21 IS IS7281A patent/IS7281A/is unknown
- 2004-05-25 ZA ZA200404067A patent/ZA200404067B/en unknown
- 2004-07-21 MA MA27796A patent/MA27169A1/fr unknown
- 2004-07-23 HR HR20040683A patent/HRP20040683A2/hr not_active Application Discontinuation
- 2004-07-27 TN TNP2004000138A patent/TNSN04138A1/fr unknown
- 2004-07-30 EC EC2004005215A patent/ECSP045215A/es unknown
- 2004-08-26 NO NO20043569A patent/NO20043569D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IS7281A (is) | 2004-05-21 |
NO20043569L (no) | 2004-08-26 |
GB0413967D0 (en) | 2004-07-28 |
PL371982A1 (en) | 2005-07-11 |
AP2004003094A0 (en) | 2004-09-30 |
TNSN04138A1 (fr) | 2007-03-12 |
CN1625549A (zh) | 2005-06-08 |
GB2400100A (en) | 2004-10-06 |
GB2400100B (en) | 2006-04-12 |
TW200302080A (en) | 2003-08-01 |
KR20040077884A (ko) | 2004-09-07 |
WO2003064391A1 (en) | 2003-08-07 |
ZA200404067B (en) | 2005-08-29 |
HN2003000051A (es) | 2003-09-24 |
MA27169A1 (fr) | 2005-01-03 |
HUP0500012A2 (hu) | 2005-04-28 |
ECSP045215A (es) | 2004-09-28 |
JP2005521668A (ja) | 2005-07-21 |
MXPA04004960A (es) | 2005-04-08 |
OA12760A (en) | 2006-07-04 |
NO20043569D0 (no) | 2004-08-26 |
EP1470109A1 (en) | 2004-10-27 |
IL162167A0 (en) | 2005-11-20 |
AR038332A1 (es) | 2005-01-12 |
BR0307339A (pt) | 2004-12-07 |
PA8564601A1 (es) | 2003-09-05 |
CA2473984A1 (en) | 2003-08-07 |
US20030216445A1 (en) | 2003-11-20 |
HRP20040683A2 (en) | 2004-10-31 |
EA200400724A1 (ru) | 2004-12-30 |
US6852863B2 (en) | 2005-02-08 |
PE20030978A1 (es) | 2003-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27632A1 (es) | Metabolitos del ácido (3-((4- terc- butilbencil)-piridin.3- sulfonil) amino) metil ) fenoxi) acético | |
RS52681B (en) | HYDROBENZOATE SALTS OF METHANICOTINE COMPOUND | |
CY1113578T1 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
CY1113362T1 (el) | Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως | |
DE60315368D1 (de) | Korrektur des Weissabgleichs | |
ECSP095220A (es) | Derivados de n-fenil-2-pirimidin-amina | |
GT200400277A (es) | Procedimiento de preparacion | |
EA201070116A1 (ru) | Новые кристаллы и способ получения 5-({[2-амино-3-(4-карбамоил-2,6-диметилфенил)пропионил]-[1-(4-фенил-1н-имидазол-2-ил)этил]амино}метил)-2-метоксибензоевой кислоты | |
HRP20080027T3 (en) | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide | |
EA200970372A1 (ru) | Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение | |
UY27618A1 (es) | Ésteres hidroxamato de ácido n-(4-fenil-sustituido)-antranílico | |
CY1107141T1 (el) | Μεθοδος για την παρασκευη της 1-(2s,3s)-2-βενζυδρυλ-ν-(5-τριτ.-βουτυλ-2-μεθοξυβενζυλ)κινουκλιδιν-3-αμινης | |
DK1467706T3 (da) | Dermalt applikationssystem for aminolevulinsyre-derivater | |
EA200802383A1 (ru) | Полиморфные формы n-гидрокси-3-[4-[[[2-(2-метил-1h-индол-3-ил)этил]амино]метил]фенил]-2e-2-акриламида | |
RS52108B (en) | 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS | |
NO20070211L (no) | Kationiske polymerer som inneholder 2-hydroksyetyl-metakrylsyre som akseleratorer for ASA-liming | |
DE602005011267D1 (de) | Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen | |
MXPA05013751A (es) | Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales. | |
ATE353927T1 (de) | Lipid-polymer konjugaten | |
EA200700364A1 (ru) | Производные амида кинуреновой кислоты как антагонисты nr2b подтипа рецептора nmda | |
NO20061316L (no) | Imidazopyndinderivater som induserbare NO-syntaseinhibitorer | |
EA200600898A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
DE602006014001D1 (de) | Herstellung von 2-aminothiazol-5-carbonsäurederivaten | |
EA200501900A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
DE50309253D1 (de) | Kosmetische Zusammensetzungen enthaltend Cyclohexanpolycarbonsäurederivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150126 |